81 related articles for article (PubMed ID: 26150235)
1. Kidney cancer: Mice with Flcn knockout in proximal tubules-an in vivo model for multiple RCC subtypes.
Thoma C
Nat Rev Urol; 2015 Aug; 12(8):420. PubMed ID: 26150235
[No Abstract] [Full Text] [Related]
2. Disruption of tubular Flcn expression as a mouse model for renal tumor induction.
Chen J; Huang D; Rubera I; Futami K; Wang P; Zickert P; Khoo SK; Dykema K; Zhao P; Petillo D; Cao B; Zhang Z; Si S; Schoen SR; Yang XJ; Zhou M; Xiao GQ; Wu G; Nordenskjöld M; Tauc M; Williams BO; Furge KA; Teh BT
Kidney Int; 2015 Nov; 88(5):1057-69. PubMed ID: 26083655
[TBL] [Abstract][Full Text] [Related]
3. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin.
Hudon V; Sabourin S; Dydensborg AB; Kottis V; Ghazi A; Paquet M; Crosby K; Pomerleau V; Uetani N; Pause A
J Med Genet; 2010 Mar; 47(3):182-9. PubMed ID: 19843504
[TBL] [Abstract][Full Text] [Related]
4. Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression.
Wu M; Si S; Li Y; Schoen S; Xiao GQ; Li X; Teh BT; Wu G; Chen J
Oncotarget; 2015 Oct; 6(32):32761-73. PubMed ID: 26418749
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia.
Chen J; Futami K; Petillo D; Peng J; Wang P; Knol J; Li Y; Khoo SK; Huang D; Qian CN; Zhao P; Dykema K; Zhang R; Cao B; Yang XJ; Furge K; Williams BO; Teh BT
PLoS One; 2008; 3(10):e3581. PubMed ID: 18974783
[TBL] [Abstract][Full Text] [Related]
6. Bringing protein biomarker discovery to the clinic.
Waybright TJ; Veenstra TD
Expert Rev Mol Diagn; 2009 May; 9(4):305-7. PubMed ID: 19435451
[No Abstract] [Full Text] [Related]
7. Superiority of rat over murine model for studies on the evolution of cancer genome.
Akatsuka S; Li GH; Toyokuni S
Free Radic Res; 2018 Dec; 52(11-12):1323-1327. PubMed ID: 29669465
[TBL] [Abstract][Full Text] [Related]
8. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
9. Are lung cysts in renal cell cancer (RCC) patients an indication for FLCN mutation analysis?
Johannesma PC; Houweling AC; Menko FH; van de Beek I; Reinhard R; Gille JJ; van Waesberghe JT; Thunnissen E; Starink TM; Postmus PE; van Moorselaar RJ
Fam Cancer; 2016 Apr; 15(2):297-300. PubMed ID: 26603437
[TBL] [Abstract][Full Text] [Related]
10. Stage-specific roles of fibulin-5 during oxidative stress-induced renal carcinogenesis in rats.
Ohara H; Akatsuka S; Nagai H; Liu YT; Jiang L; Okazaki Y; Yamashita Y; Nakamura T; Toyokuni S
Free Radic Res; 2011 Feb; 45(2):211-20. PubMed ID: 20942562
[TBL] [Abstract][Full Text] [Related]
11. Transformation of human kidney proximal tubule cells by a src-containing retrovirus.
Nanus DM; Lynch SA; Rao PH; Anderson SM; Jhanwar SC; Albino AP
Oncogene; 1991 Nov; 6(11):2105-11. PubMed ID: 1945415
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and molecular correlates between rodent and human renal cell carcinoma.
Walker C; Recio L; Funaki K; Everitt J
Prog Clin Biol Res; 1992; 376():289-302. PubMed ID: 1528923
[TBL] [Abstract][Full Text] [Related]
13. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of activator protein-2 isoforms in renal cell carcinoma.
Oya M; Mikami S; Mizuno R; Miyajima A; Horiguchi Y; Nakashima J; Marumo K; Mukai M; Murai M
Urology; 2004 Jul; 64(1):162-7. PubMed ID: 15245963
[TBL] [Abstract][Full Text] [Related]
15. Relationship between expression of drug-resistance factors and drug sensitivity in normal human renal proximal tubular epithelial cells in comparison with renal cell carcinoma.
Asakura T; Imai A; Ohkubo-Uraoka N; Kuroda M; Iidaka Y; Uchida K; Shibasaki T; Ohkawa K
Oncol Rep; 2005 Sep; 14(3):601-7. PubMed ID: 16077962
[TBL] [Abstract][Full Text] [Related]
16. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
[TBL] [Abstract][Full Text] [Related]
17. A mouse model of renal cell carcinoma.
Schmidt LS; Linehan WM
Nat Med; 2017 Jul; 23(7):802-803. PubMed ID: 28697179
[No Abstract] [Full Text] [Related]
18. Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron.
Büttner F; Winter S; Rausch S; Reustle A; Kruck S; Junker K; Stenzl A; Agaimy A; Hartmann A; Bedke J; Schwab M; Schaeffeler E
Eur Urol; 2015 Dec; 68(6):1016-20. PubMed ID: 26072688
[TBL] [Abstract][Full Text] [Related]
19. Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study.
Hughson MD; Johnson LD; Silva FG; Kovacs G
Mod Pathol; 1993 Jul; 6(4):449-56. PubMed ID: 8415591
[TBL] [Abstract][Full Text] [Related]
20. Preneoplastic and neoplastic lesions of rat hereditary renal cell tumors express markers of proximal and distal nephron.
Wolf DC; Whiteley HE; Everitt JI
Vet Pathol; 1995 Jul; 32(4):379-86. PubMed ID: 7483212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]